Publication

April, 2024

The Development of a Regulator of Human Serine Racemase for N-Methyl-D-aspartate Function

Feb, 2024

Fabrication of nanocrystal forms of ᴅ-cycloserine and their application for transdermal and enteric drug delivery systems

Dec, 2023

Ultrapure and potent tannic acid (UPPTA) is a novel inhibitor of D-amino acid oxidase to improve the N-methyl-D-aspartate function of CNS disorders

Nov, 2023

Toxicological evaluation of Ultrapure and Potent Tannic Acid (UPPTA) by inhalation exposure

Sep, 2023

SyneurRx CEO Guochuan Emil Tsai Publishes a Research Article in《The Lancet Regional Health - Western Pacific》, Indicating Sharp Increase in Suicide Attempts During the Three Years of COVID-19 Pandemic in French Polynesia

Oct, 2022

Pharmacokinetics and Safety of Sodium Benzoate, a d-Amino Acid Oxidase (DAAO) Inhibitor, in Healthy Subjects: A Phase I, Open-label Study

July, 2022

SyneuRx Publishes a Research Paper in《Journal of Alzheimer's Disease Reports》and Presents Disease-modifying Medication Results of Lithium Benzoate, Demonstrated as a Safe and Effective Drug Candidate for Alzheimer's Disease or other Neurodegenerative Disorders. (Accepted)

May, 2022

SyneuRx Publishes Pan-coronal Antiviral Therapeutic Research Results of Pentarlandir®, demonstrated as a Safe and Effective Drug Candidate, in 《ACS Pharmacology & Translation Science》

Oct, 2021

Perspective Chapter: NMDA Treatments for CNS Disorders